News

Ms Tan joins Sinobiopharma from Organon Pharmaceutical, Netherlands. Ms Tan served as a China-based unit marketing director for Organon, which was recently sold to Schering-Plough. Prior to Organon,

According to NMT Medical, the STARFlex implant can be placed in the heart to close the ventricular septal defects (VSD) using a catheter during a minimally invasive procedure,

ChemGenex placed 23.25 million fully paid ordinary shares in the company at an issue price of A$0.43 per share to raise gross proceeds of A$10 million. In addition

This Phase IIa randomized, double-blind, placebo-controlled study will evaluate the antiviral activity, safety and pharmacokinetics of TAK-652 by enrolling 40 therapy-experienced, CCR5-naive HIV-1-infected patients into one of four

Cephalon, a biopharmaceutical company, has reported positive results from a Phase III clinical trial of Nuvigil tablets as a treatment for excessive sleepiness associated with jet lag disorder.

Asterand has reported that its partner BTG plans to advance BGC20-1531, a novel EP4 receptor antagonist for the treatment of migraine headaches, to Phase IIa studies in the

Adcock Ingram will reportedly make the payment in cash, with an option for shareholders to re-invest up to 25% in the combined company. The Adcock Ingram offer equates

Champions Biotechnology, a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, has established a UK subsidiary,

Engage is expected to enroll 1,200 patients with abdominal aortic aneurysms at up to 80 medical centers across six continents. Patients who meet the single-arm study’s inclusion criteria